Sergio Dantas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sergio Dantas has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Walter Fagundes
Department of Neurosurgery, Federal University of Espirito Santo, Vitoria, Brazil
2 shared publications - Alexandre Varella Giannetti
Geneuro - International Research Group in Neuroscience, Vitória, Espírito Santo, Brazil
1 shared publication - François Dubois
LMSSC Laboratory, Conservatoire National des Arts et Métiers, 75141 Paris, France
1 shared publication - Gustavo Touzet
Service de Neurochirurgie, Hôpital Roger Salengro, Centre Hospitalier Régional Universitaire de Lille, Lille, France
1 shared publication - Nicolas Reyns
Service de Neurochirurgie, Hôpital Roger Salengro, Centre Hospitalier Régional Universitaire de Lille, Lille, France
1 shared publication - Ricardo Santos de Oliveira
Division of Neurosurgery, Department of Surgery and Anatomy, University Hospital, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
1 shared publication
Latest Publications
- Open Access
- 10 April 2026
- Published by Archives of Pediatric Neurosurgery in Archives of Pediatric Neurosurgery
- Vol. 8 (2) , e3242026
Long-term Results of Stereotactic Radiofrequency Surgery for Aggressive Behavioral in Obsessive-Compulsive Adolescent – A 10-Year Follow-up Case Report
Introduction: Aggressive and self-injurious behaviors associated with obsessive-compulsive disorder in patients with intellectual disability represent a major therapeutic challenge, particularly in cases refractory to pharmacological and behavioral treatment. In this context, stereotactic neurosurgery has been considered a last-resort option, targeting limbic and paralimbic circuits involved in emotional and behavioral regulation. Case Report: We report the case of a 17-year-old male with pharmacological resistant obsessive-compulsive disorder and severe mental retardation, with a 9-year history of refractory aggressive behavior, who underwent stereotactic neurosurgical intervention in 2006. Preoperatively, the patient exhibited high levels of aggression (MOAS score: 31). Postoperatively, there was a complete and sustained remission of aggressive episodes, with MOAS scores of 0 at all follow-up intervals up to 10 years. The patient also experienced marked improvement in obsessive-compulsive symptoms, reduction in psychotropic medications, and significant enhancement in attention, concentration, quality of life, and family satisfaction. One wound infection was reported postoperatively, with no lasting adverse effects. Conclusion: This case highlights the potential for stereotactic lesioning to induce profound and durable behavioral improvements in select patients with treatment-refractory aggression.
- 10 April 2026
- Published by Archives of Pediatric Neurosurgery in Archives of Pediatric Neurosurgery
- Vol. 8 (2) , e3242026
Open AccessLong-term Results of Stereotactic Radiofrequency Surgery for Aggressive Behavioral in Obsessive-Compulsive Adolescent – A 10-Year Follow-up Case Report
Introduction: Aggressive and self-injurious behaviors associated with obsessive-compulsive disorder in patients with intellectual disability represent a major therapeutic challenge, particularly in cases refractory to pharmacological and behavioral treatment. In this context, stereotactic neurosurgery has been considered a last-resort option, targeting limbic and paralimbic circuits involved in emotional and behavioral regulation. Case Report: We report the case of a 17-year-old male with pharmacological resistant obsessive-compulsive disorder and severe mental retardation, with a 9-year history of refractory aggressive behavior, who underwent stereotactic neurosurgical intervention in 2006. Preoperatively, the patient exhibited high levels of aggression (MOAS score: 31). Postoperatively, there was a complete and sustained remission of aggressive episodes, with MOAS scores of 0 at all follow-up intervals up to 10 years. The patient also experienced marked improvement in obsessive-compulsive symptoms, reduction in psychotropic medications, and significant enhancement in attention, concentration, quality of life, and family satisfaction. One wound infection was reported postoperatively, with no lasting adverse effects. Conclusion: This case highlights the potential for stereotactic lesioning to induce profound and durable behavioral improvements in select patients with treatment-refractory aggression.
- Top Cited PapersOpen Access
- 19 January 2026
- Published by Archives of Pediatric Neurosurgery in Archives of Pediatric Neurosurgery
- Vol. 8 (1) , e3352026
Stereotactic Brainstem Biopsy in Children: A Multicentric Case Series of 88 Patients
Introduction:Brainstem tumors pose a significant challenge in pediatric neurosurgery. Although MRI has advanced non-invasive diagnostics, up to 20% of cases show radiologic-histologic discordance, making stereotactic biopsy an important diagnostic option. This study aimed to assess the safety, diagnostic effectiveness, and clinical significance of stereotactic brainstem biopsy in a large pediatric cohort. Methods:We conducted a multicentric retrospective review of 88 children with intrinsic, non-resectable brainstem lesions who underwent stereotactic biopsy (frame-based or robot-assisted). Demographic data, surgical technique, histopathological diagnosis, and complications were analyzed. Results:Eighty-eight pediatric patients (median age 7 years, range 1.5–17; 54% male) underwent stereotactic brainstem biopsy. The most common presenting symptom was cranial nerve dysfunction, with the pons affected in 76% of cases. Stereotactic frame-based, robot-assisted, and Talairach techniques were used in 10%, 31%, and 59% of cases, respectively. The initial diagnostic yield was 97.7%. The most common diagnoses were high-grade glioma, including diffuse midline glioma (44%), followed by low-grade glioma (41%). The overall complication rate was 9.2%, primarily transient neurological deficits. No procedure-related deaths occurred. The mean follow-up period was 32 months. Conclusion:Stereotactic brainstem biopsy is a safe and effective diagnostic tool in children, offering high diagnostic yield with low morbidity. Continued advances in technique and molecular analysis further enhance its clinical value.
- 19 January 2026
- Published by Archives of Pediatric Neurosurgery in Archives of Pediatric Neurosurgery
- Vol. 8 (1) , e3352026
Top Cited PapersOpen AccessStereotactic Brainstem Biopsy in Children: A Multicentric Case Series of 88 Patients
Introduction:Brainstem tumors pose a significant challenge in pediatric neurosurgery. Although MRI has advanced non-invasive diagnostics, up to 20% of cases show radiologic-histologic discordance, making stereotactic biopsy an important diagnostic option. This study aimed to assess the safety, diagnostic effectiveness, and clinical significance of stereotactic brainstem biopsy in a large pediatric cohort. Methods:We conducted a multicentric retrospective review of 88 children with intrinsic, non-resectable brainstem lesions who underwent stereotactic biopsy (frame-based or robot-assisted). Demographic data, surgical technique, histopathological diagnosis, and complications were analyzed. Results:Eighty-eight pediatric patients (median age 7 years, range 1.5–17; 54% male) underwent stereotactic brainstem biopsy. The most common presenting symptom was cranial nerve dysfunction, with the pons affected in 76% of cases. Stereotactic frame-based, robot-assisted, and Talairach techniques were used in 10%, 31%, and 59% of cases, respectively. The initial diagnostic yield was 97.7%. The most common diagnoses were high-grade glioma, including diffuse midline glioma (44%), followed by low-grade glioma (41%). The overall complication rate was 9.2%, primarily transient neurological deficits. No procedure-related deaths occurred. The mean follow-up period was 32 months. Conclusion:Stereotactic brainstem biopsy is a safe and effective diagnostic tool in children, offering high diagnostic yield with low morbidity. Continued advances in technique and molecular analysis further enhance its clinical value.